The first and only patient-friendly preparation-free test to detect polyps before they may transform into cancer
C-Scan
Redefining colorectal cancer screening and prevention
The C-Scan System is not approved in the United States and is currently an investigational device there. The system is approved in the E.U. and Israel but it is not available for sale in any jurisdiction. This website is not intended to provide medical advice for patients or healthcare providers.
In many cases colorectal cancer can be prevented – why wait?
The C-Scan system can detect precancerous polyps, the precursors of colorectal cancer.
~25% of the asymptomatic average-risk screening population presents benign polyps in the colon, with the potential to turn into cancer over time.
It can take up to 10 years before a polyp develops into invasive cancer.
global colorectal cancer
incidence on the rise
CRC estimated new cases in 2019
0.001
million
WORLDWIDE
1
U.S.
CRC estimated related deaths
1
WORLDWIDE
1
U.S.
CRC estimated economic burden associated with CRC treatment in 2018
0
billion
WORLDWIDE
0
billion
U.S.
High Prevalence of Colorectal Polyps
1 in 4 of the asymptomatic average-risk screening population presents benign polyps in the colon, with the potential to turn into cancer over time
Screening Rates Remain Low
In the U.S., 1 in 3 adults, 50-75, is not getting screened as recommended
Most Commonly Diagnosed Cancers
Worldwide estimated figures, in millions, 2018
- Lung
- Breast
- 60% increase expected by 2030
- Prostate
- Stomach
2.1M
2.1M
1.8M
1.3M
1.0M
Lung
Breast
Colorectal
Prostate
Stomach
Prevention is key to reducing the global colorectal cancer incidence and associated mortality.
Check-Cap is committed to redefining colorectal cancer screening and prevention by overcoming many barriers to standard screening methods. We aim to drastically increase screening adherence worldwide and help millions of people stay healthy through preventive screening.
Recent Press Releases
1.Can Colorectal Polyps and Cancer Be Found Early? American Cancer Society. Early Detection, Diagnosis and Staging. Accessed July 2020.
2.Pickhardt et al. Glin. Gatro. And Hep. 2010; 8: 610
The C-Scan System is not approved in the United States and is currently an investigational device there.
The system is approved in the E.U. and Israel but it is not available for sale in any jurisdiction.
This website is not intended to provide medical advice for patients or healthcare providers.